<DOC>
<DOCNO>EP-0647617</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Ceramides, process for their preparation and their cosmetic uses
</INVENTION-TITLE>
<CLASSIFICATIONS>A61Q102	A61K3116	A61Q112	A61Q1900	A61Q300	C07C23500	C07C23508	A61K804	A61Q300	A61Q112	A61K800	A61Q302	A61K868	C07C23524	A61K830	A61Q1700	A61P1700	A61K842	A61K800	A61Q104	A61K830	A61Q512	A61K841	A61Q100	A61K3116	A61K811	A61Q1900	A61K840	A61Q302	A61Q110	A61Q500	A61Q100	A61Q106	A61K811	A61Q102	A61Q1700	A61K834	A61K836	A61K846	A61Q500	A61Q512	A61P1700	A61K804	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61Q	A61K	A61Q	A61Q	A61Q	C07C	C07C	A61K	A61Q	A61Q	A61K	A61Q	A61K	C07C	A61K	A61Q	A61P	A61K	A61K	A61Q	A61K	A61Q	A61K	A61Q	A61K	A61K	A61Q	A61K	A61Q	A61Q	A61Q	A61Q	A61Q	A61K	A61Q	A61Q	A61K	A61K	A61K	A61Q	A61Q	A61P	A61K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61Q1	A61K31	A61Q1	A61Q19	A61Q3	C07C235	C07C235	A61K8	A61Q3	A61Q1	A61K8	A61Q3	A61K8	C07C235	A61K8	A61Q17	A61P17	A61K8	A61K8	A61Q1	A61K8	A61Q5	A61K8	A61Q1	A61K31	A61K8	A61Q19	A61K8	A61Q3	A61Q1	A61Q5	A61Q1	A61Q1	A61K8	A61Q1	A61Q17	A61K8	A61K8	A61K8	A61Q5	A61Q5	A61P17	A61K8	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The ceramides according to the invention are compounds corresponding to the formula: 
<
IMAGE
>
 in which: R1 is a C11 to C21 alkyl or alkenyl radical; R2 is a linear or branched C1 to C29 hydroxyalkyl radical or a C7 to C29 hydroxyaralkyl radical, these compounds being in the form of a racemic mixture of the erythro and threo diastereoisomers, for the aminodiol part 
<
IMAGE
>
  in the proportions erythro:threo of 85:15 to 20:80. Application to cosmetic and dermopharmaceutical compositions.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
OREAL
</APPLICANT-NAME>
<APPLICANT-NAME>
L'OREAL
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
MAHIEU CLAUDE
</INVENTOR-NAME>
<INVENTOR-NAME>
PHILIPPE MICHEL
</INVENTOR-NAME>
<INVENTOR-NAME>
SEMERIA DIDIER
</INVENTOR-NAME>
<INVENTOR-NAME>
MAHIEU, CLAUDE
</INVENTOR-NAME>
<INVENTOR-NAME>
PHILIPPE, MICHEL
</INVENTOR-NAME>
<INVENTOR-NAME>
SEMERIA, DIDIER
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Compound characterized in that it corresponds to 
the formula: 


 
in which: 


R
1
 is a C
11
 to C
21
, preferably C
13
 to C
19
, alkyl 
or alkenyl radical; 
R
2
 is a linear or branched C
1
 to C
29
, preferably linear C
1
 
to C
21
, hydroxyalkyl radical or a C
7
 to C
29
, preferably C
7
 
to C
19
, hydroxyaralkyl radical, the hydroxyl group being 
in the position alpha to the carbonyl, the compound being 

in the form of a racemic mixture of the erythro and threo 
diastereoisomers for the aminodiol part 


 
in erythro/threo ratios of from 85 : 15 to 20 : 80, 

preferably from 65:35 to 45:55. 
Compound according to Claim 1, characterized in 
that R
1
 is the pentadecyl radical. 
Compound according to Claim 1, characterized in 
that the radical R
2
 is chosen from the 1-hydroxypentadecyl, 
1-hydroxyheneicosyl and D,L-1-hydroxybenzyl 

radicals. 
Compound according to Claim 1, characterized in 
that it is chosen from 2-(2'-hydroxyhexadecanoyl)aminooctadecane-1,3-diol, 

2- (2'-hydroxydocosanoyl)aminooctadecane-1,3-diol 
and 2- (D,L-mandeloyl)aminooctadecane-1,3-diol. 
Process for the preparation of a compound of 
formula (I) according to Claim 1, characterized in that 

it comprises: 

(a) acylation in an anhydrous medium, or in the presence 
of a suitable solvent, of the amine function of a 

sphingosine or of a sphinganine of formula:  
 


 
in which R
1
 is a C
11
 to C
21
 alkyl or alkenyl radical, this 
compound being a racemic mixture of the erythro and threo 

diastereoisomers in erythro/threo ratios of from 85 : 15 
to 20 : 80, preferably from 65:35 to 45:55, using an 

acylating agent chosen from acid chlorides, acid 
anhydrides, mixed anhydrides, para-nitrophenol esters, 

succinimide esters, carbodiimide esters, C
1
 to C
8
 lower 
alkyl esters, azolides and O-carboxy anhydrides of the 

corresponding 2-hydroxy acids, in order to obtain a 
compound of formula: 


 
in which R
1
 is defined as above and R
3
 represents either 
the radical R
2
 or a radical chosen from linear or 
branched C
1
 to C
29
, preferably linear C
1
 to C
21
, alkyl 
radicals or C
7
 to C
29
, preferably C
7
 to C
19
, aralkyl radicals 
which are substituted in the α position relative to 

the carbonyl, the substituent being chosen from the 
radicals -Br, -Cl, -I and -OB, -OB being a group capable 

of forming an -OH group; 
(b) isolation of the compound of formula (III); and 
(c) optionally, when R
3
 is different from R
2
, hydrolysis 
of the compound of formula (III) obtained in order to 

convert the group -OB into a hydroxyl group. 
Process according to Claim 5, characterized in 
that it comprises, after the step (a) for acylation of 

the amine function of the sphingosine or sphinganine of 
formula (II) and before the step (b) for isolation of the 

compound of formula (III), a step for protection of the 
hydroxyl groups consisting in reacting the mixture 

resulting from step (a) with a protecting agent for -OH 
groups chosen from acid anhydrides, acid halides and  

 
chlorosilanes; and, after the step (b) for isolation of 

the compound of formula (III), hydrolysis of the compound 
of formula (III), preferably in a basic medium; and 

recovery of the compound of formula (I). 
Process according to Claim 6, characterized in 
that the agent for protecting the hydroxyl groups is 

chosen from acetic anhydride, acetyl chloride, benzoyl 
chloride, benzyl chloride, benzyl bromide and the chlorosilanes 

of formulae ClSi(CH
3
)
3
, ClSi(CH
3
)
2
(tBu) and 
ClSi(tBu)(C
6
H
5
)
2
. 
Process according to any one of Claims 5 to 7, 
characterized in that the acylating agent corresponds to 

the formula R
3
COA (IV)
 
   in which R
3
 represents: 

either the radical R
2
or a radical chosen from linear or branched C
1
 to 
C
29
, preferably linear C
1
 to C
21
, alkyl radicals and C
7
 to 
C
29
, preferably C
7
 to C
19
, aralkyl radicals which are 
substituted in the α position relative to the carbonyl, 

the substituent in the α position relative to the carbonyl 
being chosen from the radicals -Br, -Cl, -I and 

-OB, -OB being a group capable of forming an -OH group; 
 
A is chosen from halogens, 


 
where R
6
 is a C
2
 to C
8
 lower alkyl radical and R
7
 is 
chosen from C
1
 to C
8
 lower alkyl radicals, 

 
on condition that, when R
3
 represents the radical R
2
, A  
 

is other than -Cl. 
Process according to Claim 8, characterized in 
that the radical -OB of the acylating agent is chosen 

from acetate, benzoate, benzyloxy, -OSi(CH
3
)
3
, 
-OSi(CH
3
)
2
(tBu) and -OSi(tBu)(C
6
H
5
)
2
 groups. 
Process according to Claim 8, characterized in 
that the acylating agent is chosen from succinimide 

2 -hydroxydecanoate, dicyclohexylcarbodiimide 2-hydroxyhexadecanoate, 
succinimide 2-hydroxydocosanoate, dicyclohexylcarbodiimide 

2-hydroxydocosanoate and succinimide 
D,L-mand
elate. 
Process according to Claim 10, characterized in 
that the compound of formula (II) is 2-aminooctadecane-1,3-diol. 
Composition for cosmetic or dermopharmaceutical 
use, characterized in that it contains a compound of 

formula (I) according to any one of Claims 1 to 4. 
Composition according to Claim 12, characterized 
in that it contains 0.05 to 20% by weight, preferably 0.1 

to 10% by weight, of compound of formula (I). 
Composition according to Claim 12 or 13, characterized 
in that it additionally comprises an adjuvant 

chosen from fatty substances, solvents, water, thickening 
agents, emulsifying agents, moisturizing products, 

softeners, sunscreen agents, germicides, dyes, preserving 
agents, perfumes, propellants and surfactants. 
Composition according to any one of Claims 12 to 
14, characterized in that it is provided in the form of 

an emulsion the fatty phase of which, representing 5 to 
60% of the total weight of the emulsion, consists essentially 

of a mixture of compound of formula (I) with at 
least one oil, the aqueous phase constituting 30 to 85% 

of the total weight of the emulsion, the emulsifying 
agent being present in an amount of from 1 to 20% by 

weight and preferably 2 to 12% by weight relative to the 
total weight of the emulsion. 
Composition according to any one of Claims 12 to 
14, characterized in that it is provided in the form of 

an oily, oleo-alcoholic or aqueous-alcoholic lotion or in  
 

the form of a gel, a solid dispersion or solid sticks, a 
spray or an aerosol foam. 
Composition according to any one of Claims 12 to 
14, characterized in that it is provided in the form of 

an aqueous dispersion of lipid spherules, consisting of 
organized molecular layers containing an encapsulated 

aqueous phase, these layers being composed of at least 
one compound of formula (I) associated with at least one 

other lipid compound. 
Composition in the form of an aqueous dispersion 
of lipid spherules according to Claim 17, characterized 

in that the other lipid compound is chosen from long 
chain alcohols and diols, sterols, phospholipids, glycolipids, 

cholesteryl sulphate and phosphate, long chain 
amines and their quaternary ammonium derivatives, dihydroxyalkylamines, 

polyoxyethylenated fatty amines, long 
chain amino alcohol esters, their salts and quaternary 

ammonium derivaties, phosphoric esters of fatty alcohols, 
alkyl sulphates and fatty acids in the form of salts. 
Composition in the form of an aqueous dispersion 
of lipid spherules according to Claim 17 or 18, characterized 

in that the spherules have a diameter between 
0.05 µm and 5 µm. 
Composition in the form of an aqueous dispersion 
of lipid spherules according to any one of Claims 17 to 

19, characterized in that the aqueous phase encapsulated 
in the spherules is water or an aqueous solution of 

active substance. 
Composition in the form of an aqueous dispersion 
of lipid spherules according to any one of Claims 17 to 

20, characterized in that the aqueous phase encapsulated 
in the spherules contains at least one cosmetic and/or 

pharmaceutical water-soluble active substance chosen from 
moistening agents, artificial tanning agents possibly 

associated with dyes, water-soluble sunscreen agents, 
antiperspirants, deodorants, astringents, freshening, 

tonic, cicatrizing, keratolytic and depilatory products, 
perfumed waters, vegetable tissue extracts, water-soluble 

dyes, anti-dandruff agents, anti-seborrhoeic agents,  
 

oxidizing agents, reducing agents, vitamins, hormones, 
enzymes, vaccines, anti-inflammatory agents, antibiotics, 

bactericides and cytotoxic or anti-tumour agents. 
Composition in the form of an aqueous dispersion 
of lipid spherules according to any one of Claims 17 to 

20, characterized in that it contains at least one lipid-soluble 
active substance chosen from lipid-soluble 

sunscreen agents, substances intended to improve the 
condition of dry or senile skin, tocopherols, vitamins E, 

F or A and their esters, retinoic acid, antioxidants, 
essential fatty acids, glycyrrhetinic acid, keratolytic 

agents and carotenoids. 
Composition in the form of an aqueous dispersion 
of lipid spherules according to any one of Claims 17 to 

22, characterized in that it comprises 2 to 70% by weight 
of a water-immiscible liquid phase chosen from oils, 

hydrocarbons, halogenated hydrocarbons, perfluorotributylamine, 
polysiloxanes, organic acid esters, ethers 

and polyethers. 
Use in cosmetics of a compound of formula (I) 
according to any one of Claims 1 to 4. 
Use of the compound of formula (I) according to 
any one of Claims 1 to 4 as a waxy constituent having 

emollient and softening properties in emulsions, dispersions, 
gels or solid sticks or in lotions for cosmetic 

use. 
Use of the compound of formula (I) according to 
any one of Claims 1 to 4 in association with at least one 

other lipid compound, for the formation of dispersions of 
lipid spherules for cosmetic use. 
Cosmetic treatment process for moisturizing the 
skin, head hair or body hair, characterized in that it 

consists in applying to the skin, head hair or body hair 
a sufficient amount of a composition according to any one 

of Claims 12 to 23. 
</CLAIMS>
</TEXT>
</DOC>
